# LOFEXIDINE (lofexidine hydrochloride) by BioCorRx Pharmaceuticals Inc: new human prescription drug listing

**Launch Signal Score:** 65/100

| Field | Value |
|---|---|
| Product | LOFEXIDINE |
| Generic name | lofexidine hydrochloride |
| NDC | 85789-901 |
| Labeler | BioCorRx Pharmaceuticals Inc |
| Product type | HUMAN PRESCRIPTION DRUG |
| Approval pathway | NDA AUTHORIZED GENERIC |
| Application number | NDA209229 |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Active ingredients | LOFEXIDINE HYDROCHLORIDE .2 mg/1 |
| Marketing start | 2026-08-15 |
| Package configurations | 2 |

## Why this score
- Prescription or biologic product.
- New generic entry: wholesalers and GPOs re-bid contracts.

Source: U.S. FDA National Drug Code (NDC) Directory via openFDA (https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=85789-901). Last refreshed: 2026-11-04T18:12:05.743Z.
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.